ALPHAPORT.AI
🇹🇼CHLITINA-KY4137
TWDUSD
SectorHealth CareIndustryBiotechWebsitehttp://www.chlitinaholding.com/
Management
趙承佑
CEO

Company information

Ticker
4137
Country
Taiwan
Sector
Health Care
Industry
Biotech

CHLITINA-KY Business Summary

CHLITINA-KY (4137.TW) operates a vertically integrated beauty and wellness ecosystem, generating the vast majority of its revenue through a high-margin B2B2C franchise model. The company’s primary business segment is its "Chlitina" branded beauty salon network, which encompasses over 4,300 locations across Greater China and Southeast Asia, where revenue is driven by the wholesale of proprietary skincare products and recurring franchise fees. Beyond its core salon operations, the company has diversified into medical aesthetics through its "Up-Great" (UPLIDER) clinics, direct-to-consumer retail via the "Xinmeili" e-commerce platform, and emerging investments in anti-aging and regenerative medicine. In the competitive landscape, CHLITINA-KY maintains a leading market share in the professional beauty services sector, positioned as a premium provider relative to direct competitors such as Natural Beauty (0157.HK), Jourdeness (4190.TW), and Nu Skin Enterprises (NUS). The company was founded in 1989 by Dr. Chen Wu-Kang, a pioneer in amino acid-based skincare who remains a central figure in the broader Kelti Group. Current leadership is headed by Chairman Chen Pi-Hua (Joanna Chen), the founder's daughter, who is credited with the brand's successful expansion into the mainland Chinese market and its 2013 listing on the Taiwan Stock Exchange. The executive team is led by CEO Chao, Cheng-Yu (Ryan Chao), a third-generation leader who has spearheaded the firm’s digital transformation and the integration of medical aesthetics into the franchise ecosystem. The board of directors includes significant representation from the founding Chen family, with major institutional backing from regional investment firms, ensuring a stable governance structure focused on long-term brand equity and technological innovation in biotechnology.

Updated 2026-07-29 · TW Taiwan public company filings
Financial Metric TrendsQuarterly⌄
Business Overview is available publicly. Financials, KPIs, reports, transcripts and the rest of Research require the Research tier.